South Africa has kicked off its vaccination campaign against COVID-19 by injecting healthcare workers with the shot developed by Johnson & Johnson as part of an observational study. The first healthcare worker was inoculated at 1pm (11:00 GMT) on Wednesday at the Khayelitsha District Hospital in Cape Town, following the arrival of 80,000 vaccine doses at Johannesburg’s international airport the night before. President Cyril Ramaphosa, along with Health Minister Zweli Mkhize and Deputy Health Minister Joe Phaahla, were also among the first to be vaccinated. The single-dose vaccine developed by Johnson & Johnson is the first to be used outside a clinical trial and is not yet approved for general use anywhere in the world. The company’s jab has been shown to offer 57 percent protection against moderate to severe COVID-19 infections caused by a more transmissible new variant, the 501Y.V2 also known as B.1.351, which counts for 90 percent of cases in the country. The Johnson & Johnson vaccine, along with the one developed by Novavax (50 percent protection) are the only two vaccines that have shown efficacy in clinical trials held in South Africa against the new variant.
SOURCE:AL JAZEERA
More Stories
Lagos Rising: Meet the African Designers Who are Ushering in a New Guard of Fashion
My Life in Food: Idris Elba on African Cuisine and Cooking with his Mum
In His Imaginative Debut Feature, Walé Oyéjidé Brings Together Elements of His Life’s Work
What is Zellige Tile?
Ousmane Sembène at 100: A Tribute to Senegal’s ‘Father of African Cinema’
Inside an Ultra-exclusive Lodge on the Fringe of Etosha National Park
Tourists Flock to Nigerian Cave And Waterfall For Its ‘Healing Powers’
Morocco is Just as Worthy for a Sun Trip
African Markets Offer Unique Goods and Experiences
Get to Know East Africa’s Art Scene
Mo Ibrahim’s Index Looks at Africa’s State of Governance
France to Give Burkina Faso What It Wants